
-

Crispr Therapy Shown to Remove E. Coli in Gut
New research with lab animals shows gene-edited viruses can target and remove harmful E. coli bacteria from the gut, including strains usually resistant to antibiotics.
-

Trial Underway Testing Psychedelic Drug for Depression
The first participant in a clinical trial received a dose of a psychedelic therapy, assessing the experimental compound in people with treatment resistant depression.
-

DNA Test Detects Early Bladder Cancer in Urine
A genomic analysis of urine samples is shown to predict the most common form of bladder cancer years before symptoms appear.
-

Biotech to Design Disease-Blocking Drugs, Gains $75M
A new company that says it can stop disease-causing proteins from forming in cells began public operations today, and is raising $75 million in its first venture round.
-

Infographic – National Attitudes on Entrepreneurship
To start a new business, one needs to judge local business opportunities against an appetite for risk, with those attitudes now revealed for individual countries.
-

Light-Activated Therapy Improves Vision in Inherited Disease Trial
A clinical trial shows a light-activated protein from an injected gene improves visual abilities in people with advanced retinitis pigmentosa, an inherited eye disorder.
-

Low-Dose Covid-19 Vaccine Generates Strong Immune Response
Ultra-low quantities of an experimental Covid-19 protein vaccine delivered in synthetic cell components are shown in lab animals to generate strong immune responses.
-

Real World Evidence Shown to Emulate Some Clinical Trials
A study of insurance claims records matching the design of randomized clinical trials shows claims data can in some cases resemble clinical trial results to make causal inferences.
-
A Successful Growth Strategy For Your Small Business
If you dream of growing your business and pushing the boundaries, this guide outlines key steps to take to implement a successful growth plan.
-

Venture Capital Group to Boost Climate Actions
A venture investor coalition in the U.S. and Europe announced plans to reach net zero emissions by 2030 and help start-up companies quickly achieve their zero emissions goals.